Connell Consulting
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
PwC: BupaCSH MSK contract could damage local trust

An independent report on BupaCSH’s musculoskeletal services (MSK) contract has stated that the new service could “negatively impact” the local NHS trust.

Coastal West Sussex Clinical Commissioning Group (CCG) awarded BupaCSH a five-year, £235 million contract to deliver local MSK services in September 2014. Previously, the services were managed by Western Sussex Hospitals Foundation Trust.

However, Coastal West Sussex CCF and the trust jointly commissioned PwC to carry out an independent assessment of the contract after the trust raised concerns about its impact on wider hospital services.

PwC’s report concluded that it could “achieve benefits” but that the “cumulative impact of loss of MSK services” could add up to £13.4 million over the five-year contract. This would result in the trust falling into deficit. This could happen “specifically if providers conduct outpatient activity but do not also provide inpatient services”.

This news comes after Bedford Hospital NHS Trust refused to sign the contract for local MSK services awarded to Circle in November 2014 due to potential impact on the viability of the trauma service.

Marianne Griffiths, chief executive of the Western Sussex Hospitals Foundation Trust, said that if the implications were not mitigated it would “seriously affect the care we are able to provide our patients in our hospitals”.

The new service is still due to begin in April, but if this is to be achieved “there is a considerable amount of work to be completed by all parties,” the auditors concluded.

The CCG’s chief clinical officer Katie Armstrong said the group will now “fully explore the financial and clinical implications” and stated that the contract will not be signed until it has been reassured.

BupaCSH is a joint venture between Bupa and Central Surrey Healthcare. Under the terms of the Sussex MSK contract, BupaCSH is the prime contractor and has to work with other providers to coordinate all treatment and care for people with muscle, joint and bone conditions in the area.


Related articles:

Posted on: 07/01/2015

Latest news stories

21/08/2017
Councils have been warned that they must reduce hospital bed blocking by next month – in some cases by up to 70% – or face cuts to funding.
21/08/2017
Bridges Fund Management partner Garret Turley has left the firm after six years to join August Equity.
17/08/2017
Health tech start-up Medopad, which is backed by pharma company Bayer, intends to raise $30 million (£29.3 million) in private investment.
15/08/2017
Corby Clinical Commissioning Group has been ordered to recompense an independent provider after it failed to pay the full NHS tariff over several years.
15/08/2017
Project Phoenix, the plan to establish six public-private partnerships to dispose of unneeded NHS assets, is expected to be receive government approval within weeks.


Civica


politics

After a dramatic election result, Ploy Radford asks what our new government means for health and social care
Read more


HealthInvestor Events


public-private partnership
Sarah Williams weighs up the public-private partnership models driving change in health and social care
Read more


Christie + Co

HealthInvestor App


charity profile

Waymarks is tackling the more challenging end of the adult learning disabilities sector. Ploy Radford reports
Read more



interview - David McKinney

Real integration of health and care means throwing housing and technology into the bargain too, according to Tunstall's David McKinney. Sarah Williams hears more
Read more



HealthInvestor blog
The outgoing chief inspector of hospitals may not think the NHS necessarily needs more money to do things better, but social care does if it is to help the health service with bed blocking

Click here to view the Editor's blog


Howard de Walden Estate chief executive Andrew Hynard has his hands on a £1.1 billion medical portfolio steeped in the history of Harley Street. But staying relevant means keeping a finger firmly on the pulse of innovation, he tells Sarah Williams
HealthInvestor UK catches up with Professor Takanori Shibata and his robotic creation PARO, 15 years after it first entered care homes, to find out how the fluffy seal is advancing care
Managing director at Regard Group
Clare Connell and Henry Hunt of Connell Consulting investigate the implications of the opiate and prescription-only medicines addiction in the UK
Candesic’s Dr Joe Taylor considers the implications of the UK’s shortage of doctors

Click here to search all feature articles